If you are considering converting from one to the other , baseline labs before the switch and follow-up labs at 4 and 12 weeks help establish how your body responds to the new medication specifically
Medication options strongly depend on the treatment of specific symptoms
Physical symptoms may include weakness, pale or yellowish skin, numbness or tingling in extremities, balance difficulties, mood changes including depression or irritability, and tongue inflammation
Tirzepatide, which acts on both GLP-1 and GIP receptors, is an increasingly popular alternative
doi: 10.1186/s12889-019-7372-2
The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice